These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26743898)

  • 1. Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes.
    Ehlerding EB; Goel S; Cai W
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):938-940. PubMed ID: 26743898
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT.
    Petersen AL; Henriksen JR; Binderup T; Elema DR; Rasmussen PH; Hag AM; Kjær A; Andresen TL
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):941-952. PubMed ID: 26646780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of copper-64 radiopharmaceuticals as cancer theranostics.
    Boschi A; Martini P; Janevik-Ivanovska E; Duatti A
    Drug Discov Today; 2018 Aug; 23(8):1489-1501. PubMed ID: 29635027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiometallic Complexes of DO3A-Benzothiazole Aniline for Nuclear Medicine Theranostics.
    Park JA; Lee JW; Kim HK; Shin UC; Lee KC; Kim TJ; Chang Y; Kim KM; Kim JY; Lee YJ
    Mol Pharm; 2018 Mar; 15(3):1133-1141. PubMed ID: 29381860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper-64: a real theranostic agent.
    Gutfilen B; Souza SA; Valentini G
    Drug Des Devel Ther; 2018; 12():3235-3245. PubMed ID: 30323557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.
    Sonali ; Singh RP; Singh N; Sharma G; Vijayakumar MR; Koch B; Singh S; Singh U; Dash D; Pandey BL; Muthu MS
    Drug Deliv; 2016 May; 23(4):1261-71. PubMed ID: 26961144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-TPGS decorated theranostic liposomes for brain targeted delivery.
    Sonali ; Singh RP; Sharma G; Kumari L; Koch B; Singh S; Bharti S; Rajinikanth PS; Pandey BL; Muthu MS
    Colloids Surf B Biointerfaces; 2016 Nov; 147():129-141. PubMed ID: 27497076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
    Xing H; Hwang K; Lu Y
    Theranostics; 2016; 6(9):1336-52. PubMed ID: 27375783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 64Cu loaded liposomes as positron emission tomography imaging agents.
    Petersen AL; Binderup T; Rasmussen P; Henriksen JR; Elema DR; Kjær A; Andresen TL
    Biomaterials; 2011 Mar; 32(9):2334-41. PubMed ID: 21216003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper radiopharmaceuticals for theranostic applications.
    Ahmedova A; Todorov B; Burdzhiev N; Goze C
    Eur J Med Chem; 2018 Sep; 157():1406-1425. PubMed ID: 30282317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of
    Jensen AI; Severin GW; Hansen AE; Fliedner FP; Eliasen R; Parhamifar L; Kjær A; Andresen TL; Henriksen JR
    J Control Release; 2018 Jan; 269():100-109. PubMed ID: 29122662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer theranostic applications of lipid-based nanoparticles.
    Tang WL; Tang WH; Li SD
    Drug Discov Today; 2018 May; 23(5):1159-1166. PubMed ID: 29660478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
    Lymperis E; Kaloudi A; Sallegger W; Bakker IL; Krenning EP; de Jong M; Maina T; Nock BA
    Bioconjug Chem; 2018 May; 29(5):1774-1784. PubMed ID: 29664606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.
    Ullrich M; Bergmann R; Peitzsch M; Zenker EF; Cartellieri M; Bachmann M; Ehrhart-Bornstein M; Block NL; Schally AV; Eisenhofer G; Bornstein SR; Pietzsch J; Ziegler CG
    Theranostics; 2016; 6(5):650-65. PubMed ID: 27022413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (177)Lu-Labeled Cerasomes Encapsulating Indocyanine Green for Cancer Theranostics.
    Jing L; Shi J; Fan D; Li Y; Liu R; Dai Z; Wang F; Tian J
    ACS Appl Mater Interfaces; 2015 Oct; 7(39):22095-105. PubMed ID: 26398723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-pot synthesized Cu/Au/Pt trimetallic nanoparticles with enhanced catalytic and plasmonic properties as a universal platform for biosensing and cancer theranostics.
    Ye X; He X; Lei Y; Tang J; Yu Y; Shi H; Wang K
    Chem Commun (Camb); 2019 Feb; 55(16):2321-2324. PubMed ID: 30720028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote Loading of (64)Cu(2+) into Liposomes without the Use of Ion Transport Enhancers.
    Henriksen JR; Petersen AL; Hansen AE; Frankær CG; Harris P; Elema DR; Kristensen AT; Kjær A; Andresen TL
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):22796-806. PubMed ID: 26426093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.